DS1040-B-U107: Phase 1B, Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of DS-1040B when added to standard of care in subjects with submassive pulmonary embolism
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Daiichi Sankyo Inc
Start Date
September 3, 2017
End Date
August 31, 2019
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Daiichi Sankyo Inc
Start Date
September 3, 2017
End Date
August 31, 2019